NCT01920802View on ClinicalTrials.gov

Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo

PHASE4CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

olanzapine

5mg BID up to 4 weeks

DRUG

iloperidone

6 mg BID up to 4 weeks

DRUG

Placebo

BID up to 4 weeks

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

New York State Psychiatric Institute

OTHER